Acute Lymphoblastic Leukemia - FDA Approves Erwinaze
Links shared publicly online about this topic.
- 0total visits
Acute Lymphoblastic Leukemia - FDA Approves Erwinaze
White blood cells (Lymphocytes) help the body fight infection, however acute lymphoblastic leukemia, also known as cancer of the white blood cells, is characterized by a production of excess lymph
View full resource at medicalnewstoday.com
Tags: Infection, Cancer, Leukemia, FDA
Most Recently Shared on November 21, 2011 at 1:05 pm By:
Acute Lymphoblastic Leukemia - FDA Approves Erwinaze http://t.co/9IYLa3Ls #regulatory
Also Shared By:
Micromet Receives European Orphan Drug Designation for Treatment of Acute Lymphoblastic Leukemia with BiTE Antibody Blinatumomab
news.prnewswire.com — “Micromet Receives European Orphan Drug Designation for Treatment of Acute Lymphoblastic Leukemia with BiTE Antibody Blinatumomab” View full resource at news.prnewswire.com
Most Recently Shared on August 3, 2009 at 2:50 pm By:
Good news! European (EMEA) approval for Blinatumomab, BITE antibdy treatment for #leukemia. Promise for B-Cell #Lymphoma http://bit.ly/1cCBn
Advertisement
MNT Cancer News
@mnt_cancer
Acute Lymphoblastic Leukemia - FDA Approves Erwinaze http://t.co/shA4UEtu #cancer
1 year ago...